Related Experiment Video
Updated: Mar 20, 2026

08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
13.7K
Glaucoma treatment adherence at a United Kingdom general practice
1Department of Ophthalmology, Stoke Mandeville Hospital, Aylesbury, Buckinghamshire, UK.
Eye (London, England)
|June 4, 2016
Summary
Patient adherence to glaucoma therapy improves with age. Younger patients showed poorer adherence, suggesting a need for targeted educational interventions regarding glaucoma management and medication use.
Area of Science:
- Ophthalmology
- Public Health
- Pharmacoeconomics
Background:
- Glaucoma is a leading cause of irreversible blindness worldwide.
- Effective management relies on consistent patient adherence to topical medication regimens.
- Suboptimal adherence can lead to disease progression and vision loss.
Purpose of the Study:
- To assess patient adherence to glaucoma therapy using electronic health records.
- To identify demographic and clinical factors associated with glaucoma medication adherence.
Main Methods:
- Retrospective analysis of prescribing records from a UK general practice (13,422 patients).
- Identified patients diagnosed with glaucoma or related conditions and prescribed topical treatments.
- Defined adherence as the deviation from the expected 12 annual prescriptions (one per month).
Main Results:
- 206 patients (74%) were prescribed glaucoma treatment.
- Adherence significantly varied by age, with younger patients exhibiting lower adherence (P=0.0347).
- No significant differences in adherence were found based on medication class, diagnosis, comorbidities, or number of drops.
Conclusions:
- Glaucoma treatment adherence increases with patient age.
- Younger patients may benefit from enhanced education on glaucoma and its treatment.
- Older patients might require interventions focused on optimizing eye drop technique to reduce potential wastage.
Related Concept Videos
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Glaucoma: Overview
1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
Ophthalmic Drug Delivery Systems
191
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
191
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
796
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
796

